European Journal of Medicinal Chemistry p. 1214 - 1222 (2018)
Update date:2022-08-04
Topics:
Angeli, Andrea
Trallori, Elena
Ferraroni, Marta
Di Cesare Mannelli, Lorenzo
Ghelardini, Carla
Supuran, Claudiu T.
A series of disubstituted selenazole derivatives was synthetized and evaluated as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors against the human (h) isoforms hCA I, II, IV, VA, VB and IX, involved in a variety of diseases including glaucoma, retinitis pigmentosa, epilepsy, arthritis and tumors. The investigated compounds showed potent inhibition against the tumor-associated transmembrane hCA IX, with KIs in the subnanomolar – low nanomolar range, and were evaluated for their effects on cell viability against the human prostate (PC3) and breast (MDA-MB-231) cancer cell lines, showing effective anti-tumor activity. These selenazoles are interesting leads for the development of new, isoform-selective CA IX inhibitors.
View MoreBeijing Apis Biotechnology Co., Ltd.
Contact:86-010-67856775-8551
Address:NO.4PUHUANGYU ROAD,FENTAI DISTRICT, BEIJING, CHINA
SuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Contact:86-379-63338609
Address:Jiudian Village,Deting Town,Song County,Luoyang
Shanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
Taizhou Chenyi chemical co. LTD,
Contact:13736652831
Address:NO.273 SHANGHAI SOUTH STREET,LUQIAO DISTRICT,ZHEJIANG PROVINCE,CHINA.
Doi:10.1016/j.cplett.2005.03.127
(2005)Doi:10.1093/geront/41.6.723
(1921)Doi:10.1016/j.molcata.2013.11.032
(2014)Doi:10.1016/j.tetlet.2018.09.056
(2018)Doi:10.1055/s-2008-1072504
(2008)Doi:10.1007/s10593-006-0097-z
(2006)